Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
9 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Clopidogrel Viatris (previously Clopidogrel Taw Pharma)“
Suchtreffer
Begriffe & Kennungen
Clopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · In ACTIVE-A, the rate of major bleeding was greater in the clopidogrel + ASA group than in the placebo + ASA g
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · In CURE, there was no excess in major bleeds with clopidogrel plus ASA within 7 days after coronary bypass gra
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · In TARDIS, patients with recent ischemic stroke receiving intensive antiplatelet therapy with three medicinal
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · Summary of the safety profile Clopidogrel has been evaluated for safety in more than 44,000 patients who have
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · System Organ Common Uncommon Rare Very rare, not known* Class Blood and the Thrombocytopenia, Neutropenia, Thr
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · Tabulated list of adverse reactions Adverse reactions that occurred either during clinical studies or that wer
Eintrag öffnen